Cannara Biotech Inc (LOVE) — Cash Flow Quality Index
Cannara Biotech Inc (LOVE) has a Cash Flow Quality Index of 7.66x as of November 2025. Operating cash flow of CA$7.96 Million exceeds net income of CA$1.04 Million, indicating high earnings quality where cash backs reported profits. Explore Cannara Biotech Inc operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cannara Biotech Inc Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Cannara Biotech Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Cannara Biotech Inc (LOVE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Cannara Biotech Inc (2022–2025)
Year-by-year earnings quality comparison for Cannara Biotech Inc. For live market cap and the full company financial profile, see LOVE market cap.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.53x | CA$20.01 Million | CA$13.08 Million | ▼ -7.8% |
| 2024 | 1.66x | CA$10.68 Million | CA$6.44 Million | ▲ +95.0% |
| 2023 | 0.85x | CA$5.91 Million | CA$6.95 Million | ▲ +132.3% |
| 2022 | -2.64x | CA$-6.08 Million | CA$2.31 Million | — |